Technology News and Research

RSS

Discovery may lead to curing of Alzheimer's and Parkinson's disease via photo therapy

Researchers at Chalmers University of Technology in Sweden, together with researchers at the Polish Wroclaw University of Technology, have made a discovery that may lead to the curing of diseases such as Alzheimer's, Parkinson's and Creutzfeldt-Jakob disease (the so called mad cow disease) through photo therapy.

3 Nov 2013

Immunocore’s Phase IIa clinical trial for IMCgp100 in melanoma initiates in the UK and USA

Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.

1 Nov 2013

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Crown serves pharmaceutical companies and biotech companies. We have two areas of focus: oncology and metabolic diseases. In the oncology space we focus on pre-clinical services. Essentially, we have all the tools to help our customers move from target discovery, target validation, to a clinical candidate.

31 Oct 2013

Aethon receives two prestigious awards for leadership, growth and innovation

Aethon is proud to be the recipient of two separate awards recognizing their leadership, growth and innovation.

31 Oct 2013

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

Protego Medical Pty Ltd, an early stage medical technology company developing a medical device for sternal protection during cardiac surgery, was launched today with AU$2M start-up financing from Australia’s Medical Research Commercialisation Fund (MRCF). At the same time, the Company announced the appointment of Pablo Solis as CEO.

31 Oct 2013

Nanosonics named healthcare industry’s Company of the Year for 2013

Nanosonics Limited (ASX: NAN) is pleased to announce it has been named the healthcare industry’s Company of the Year for 2013.

31 Oct 2013

Reinnervate, Oncotest and SBH partner to offer 3D tumour cell screening services

3D cell culture company Reinnervate Ltd today announced partnerships with two oncology-focussed CRO's to offer 3D tumour cell screening services. The CROs, Oncotest GmbH (Freiburg, Germany) and SBH Sciences (Natick, MA, USA) will both offer a new service for clients wishing to try out cancer 3D cell culture screening for the first time or who wish to evaluate new tumour types in their models.

31 Oct 2013

Prestigious Janssen Industry Excellence Awards announced

The prestigious Janssen Industry Excellence Awards were announced as part of the official opening reception for the AusBiotech 2013 Conference at Brisbane City Hall last night; among them, internationally-acclaimed Brisbane-based researcher, Professor Ian Frazer.

31 Oct 2013

Cellectricon to demonstrate Cellaxess technology at Neuroscience 2013

Cellectricon, a leading provider of advanced cell-based screening technologies and services, will be presenting new data at Neuroscience 2013, 9-13 November, San Diego (USA).

From Cellectricon 31 Oct 2013

Aetna selects Swiss Life to offer international health care benefits and services

Aetna, a leading global diversified health care solutions company, has been selected by Zurich-based Swiss Life, a leading life and pension insurer, to offer international health care benefits and services for expatriates out of Singapore to its roster of multinational customers, effective immediately.

31 Oct 2013

President to invoke 'Romneycare' to defend health law

President Barack Obama heads to the same room in Boston where the Massachusetts health law was signed to call for bipartisanship to help the Affordable Care Act succeed.

31 Oct 2013

NJIT professor receives Innovators Award from New Jersey Inventors Hall of Fame

Treena Livingston Arinzeh, PhD, of West Orange, a professor of biomedical engineering at New Jersey Institute of Technology (NJIT), received an Innovators Award from the New Jersey Inventors Hall of Fame (NJIHoF) in recognition of her research and inventions utilizing biomaterials and regenerative medicines for orthopedic and neural disorders.

31 Oct 2013

Dendrites multiply the brain's computing power

Dendrites, the branch-like projections of neurons, were once thought to be passive wiring in the brain. But now researchers at the University of North Carolina at Chapel Hill have shown that these dendrites do more than relay information from one neuron to the next.

31 Oct 2013

Researchers receive grant to develop new device that identifies healthy sperm cells for IVF

The World Health Organization estimates more than 70 million couples worldwide are unable to conceive each year, with close to a third of those cases attributable solely to issues with male fertility-including low sperm count and low sperm motility (a limited ability to swim).

31 Oct 2013

New study addresses general barriers inhibiting cancer research commercialization

A new study led by the University of Kentucky Markey Cancer Center Assistant Director for Research Nathan Vanderford cites a combination of factors that prevent academic-based cancer research faculty from ultimately commercializing their work.

31 Oct 2013

GHIT Fund to host panel discussion to examine recent successes, setbacks in global health

The Global Health Innovative Technology Fund, along with the New York Academy of Sciences and Japan Society, will host a panel discussion - comprised of preeminent global health experts - to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.

31 Oct 2013

Meclizine drug has the potential to treat certain infectious diseases and cancer

Meclizine, an over-the-counter drug used for decades to treat nausea and motion sickness, has the potential for new uses to treat certain infectious diseases and some forms of cancer, according to Dr. Vishal M. Gohil, Texas A&M AgriLife Research biochemist.

31 Oct 2013

UofL researcher enters into license and research collaboration agreement with Novartis

The University of Louisville today announced that researcher Dr. Suzanne Ildstad, representing Regenerex LLC, has entered into a license and research collaboration agreement with Novartis to provide access to stem cell technology that has the potential to help transplant patients avoid taking anti-rejection medicine for life and could serve as a platform for treatment of other diseases.

31 Oct 2013

New voting joystick could enable people with dexterity impairments to cast ballots independently

A voting joystick created at Michigan State University could eventually enable people with dexterity impairments, senior citizens and others to exercise their right to cast ballots independently.

30 Oct 2013

IRS will face difficulties in collecting health law penalties

When Congress passed the health law in 2010, it also banned the Internal Revenue Service from using its regular enforcement techniques.

30 Oct 2013

Technology News and Research

Discovery may lead to curing of Alzheimer's and Parkinson's disease via photo therapy

Immunocore’s Phase IIa clinical trial for IMCgp100 in melanoma initiates in the UK and USA

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Aethon receives two prestigious awards for leadership, growth and innovation

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

Nanosonics named healthcare industry’s Company of the Year for 2013

Reinnervate, Oncotest and SBH partner to offer 3D tumour cell screening services

Prestigious Janssen Industry Excellence Awards announced

Cellectricon to demonstrate Cellaxess technology at Neuroscience 2013

Aetna selects Swiss Life to offer international health care benefits and services

President to invoke 'Romneycare' to defend health law

NJIT professor receives Innovators Award from New Jersey Inventors Hall of Fame

Dendrites multiply the brain's computing power

Researchers receive grant to develop new device that identifies healthy sperm cells for IVF

New study addresses general barriers inhibiting cancer research commercialization

GHIT Fund to host panel discussion to examine recent successes, setbacks in global health

Meclizine drug has the potential to treat certain infectious diseases and cancer

UofL researcher enters into license and research collaboration agreement with Novartis

New voting joystick could enable people with dexterity impairments to cast ballots independently

IRS will face difficulties in collecting health law penalties

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News